
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1048 | 1039 | 1104 | 1332 | 1823 | 2199 |
Fund Return | 4.8% | 3.91% | 10.45% | 10.04% | 12.75% | 8.2% |
Place in category | 333 | 308 | 1637 | 838 | 322 | 315 |
% in Category | 16 | 14 | 89 | 58 | 28 | 50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IA Clarington Dividend Grwth Cl F10 | 1.88B | 4.00 | 8.64 | 8.35 | ||
IA Clarington Dividend Growth F6 | 1.88B | 4.00 | 8.65 | 8.37 | ||
IA Clarington Dividend Growth Cl E6 | 1.88B | 3.84 | 7.61 | 7.33 | ||
IA Clarington Canadian Small Cap F | 826.92M | -2.10 | 8.48 | 7.70 | ||
IA Clarington Strategic Eq Fund F | 776.22M | 2.39 | 6.98 | 7.17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 17.07B | -0.93 | 23.49 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.18B | 2.07 | 11.83 | 10.97 | ||
Capital Group Glbal Equity Fd A CAD | 13.18B | 1.89 | 10.61 | 9.74 | ||
Capital Group Glbal Equity Fd D CAD | 13.18B | 2.03 | 11.47 | 10.50 | ||
EdgePoint Glbl Port non HST Sr F | 12.47B | 6.12 | 9.99 | 8.91 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Centene | US15135B1017 | 4.53 | 60.04 | -0.32% | |
Admiral Group | GB00B02J6398 | 3.70 | 2,823.0 | -0.42% | |
Alphabet A | US02079K3059 | 3.40 | 154.33 | -4.88% | |
Hikma Pharma | GB00B0LCW083 | 3.28 | 1,945.00 | -0.92% | |
Royal Unibrew | DK0060634707 | 3.28 | 551 | -0.63% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review